BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34148403)

  • 1. Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging.
    Matsumoto KI; Nakanishi I; Zhelev Z; Bakalova R; Aoki I
    Antioxid Redox Signal; 2022 Jan; 36(1-3):95-121. PubMed ID: 34148403
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Hyodo F; Eto H; Naganuma T; Koyasu N; Elhelaly AE; Noda Y; Kato H; Murata M; Akahoshi T; Hashizume M; Utsumi H; Matsuo M
    Antioxid Redox Signal; 2022 Jan; 36(1-3):172-184. PubMed ID: 34015957
    [No Abstract]   [Full Text] [Related]  

  • 3. Redox-Based Theranostics of Gastric Ulcers Using Nitroxyl Radicals.
    Yasukawa K
    Antioxid Redox Signal; 2022 Jan; 36(1-3):160-171. PubMed ID: 34498915
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain redox imaging.
    Matsumoto K; Hyodo F; Anzai K; Utsumi H; Mitchell JB; Krishna MC
    Methods Mol Biol; 2011; 711():397-419. PubMed ID: 21279614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest.
    Matsumoto KI; Mitchell JB; Krishna MC
    Free Radic Res; 2018 Feb; 52(2):248-255. PubMed ID: 29320888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility decay rates of t(1)-weighted magnetic resonance imaging contrast based on redox-sensitive paramagnetic nitroxyl contrast agents.
    Matsumoto K
    Biol Pharm Bull; 2009 Apr; 32(4):711-6. PubMed ID: 19336910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Functional Imaging for Cancer/Tumor Microenvironments Based on MRI, EPRI, and PET.
    Matsumoto KI; Mitchell JB; Krishna MC
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of EPR imaging and T1-weighted MRI for efficient imaging of nitroxyl contrast agents.
    Matsumoto K; Narazaki M; Ikehira H; Anzai K; Ikota N
    J Magn Reson; 2007 Jul; 187(1):155-62. PubMed ID: 17433743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain contrasting ability of blood-brain-barrier-permeable nitroxyl contrast agents for magnetic resonance redox imaging.
    Matsumoto K; Yamasaki T; Nakamura M; Ishikawa J; Ueno M; Nakanishi I; Sekita A; Ozawa Y; Kamada T; Aoki I; Yamada K
    Magn Reson Med; 2016 Sep; 76(3):935-45. PubMed ID: 26414669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition of nitroxyl contrast agents as an in vivo tissue redox probe: comparison of pharmacokinetics by the bile flow monitoring (BFM) and blood circulating monitoring (BCM) methods using X-band EPR and simulation of decay profiles.
    Okajo A; Matsumoto K; Mitchell JB; Krishna MC; Endo K
    Magn Reson Med; 2006 Aug; 56(2):422-31. PubMed ID: 16810697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of volume limitation for tissue redox status measurements using nitroxyl contrast agents: a comparison of X-band EPR bile flow monitoring (BFM) method and 300 MHz in vivo EPR measurement.
    Ui I; Okajo A; Endo K; Utsumi H; Matsumoto K
    J Magn Reson; 2006 Jul; 181(1):107-12. PubMed ID: 16632393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed Electron Paramagnetic Resonance Imaging: Applications in the Studies of Tumor Physiology.
    Kishimoto S; Matsumoto KI; Saito K; Enomoto A; Matsumoto S; Mitchell JB; Devasahayam N; Krishna MC
    Antioxid Redox Signal; 2018 May; 28(15):1378-1393. PubMed ID: 29130334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo and In Situ Detection of Macromolecular Free Radicals Using Immuno-Spin Trapping and Molecular Magnetic Resonance Imaging.
    Towner RA; Smith N
    Antioxid Redox Signal; 2018 May; 28(15):1404-1415. PubMed ID: 29084431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of novel nitroxyl radicals with reduction stability.
    Kinoshita Y; Yamada K; Yamasaki T; Mito F; Yamato M; Kosem N; Deguchi H; Shirahama C; Ito Y; Kitagawa K; Okukado N; Sakai K; Utsumi H
    Free Radic Biol Med; 2010 Dec; 49(11):1703-9. PubMed ID: 20828609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI.
    Hyodo F; Murugesan R; Matsumoto K; Hyodo E; Subramanian S; Mitchell JB; Krishna MC
    J Magn Reson; 2008 Jan; 190(1):105-12. PubMed ID: 18006345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous imaging of an enantiomer pair by electron paramagnetic resonance using isotopic nitrogen labeling.
    Miyake Y; Wang X; Amasaka M; Itto K; Xu S; Arimoto H; Fujii H; Hirata H
    Anal Chem; 2013 Jan; 85(2):985-90. PubMed ID: 23249381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPR signal reduction kinetic of several nitroxyl derivatives in blood in vitro and in vivo.
    Zhelev Z; Matsumoto K; Gadjeva V; Bakalova R; Aoki I; Zheleva A; Anzai K
    Gen Physiol Biophys; 2009 Dec; 28(4):356-62. PubMed ID: 20097958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals.
    Utsumi H; Yamada K; Ichikawa K; Sakai K; Kinoshita Y; Matsumoto S; Nagai M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1463-8. PubMed ID: 16432234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents.
    Matsumoto K; Hyodo F; Matsumoto A; Koretsky AP; Sowers AL; Mitchell JB; Krishna MC
    Clin Cancer Res; 2006 Apr; 12(8):2455-62. PubMed ID: 16638852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nano-theranostics and Nitroxyl Radical-labeled Antitumor Agents for Magnetic Resonance Imaging].
    Aoki I
    Yakugaku Zasshi; 2016; 136(8):1087-91. PubMed ID: 27477722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.